Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dose, safety, and efficacy of a drug formulation designed to treat children infected with the human immunodeficiency virus (HIV).
Researchers at the University of Colorado Anschutz Medical Campus have contributed to the confirmation of the dose, safety, and efficacy of a medication formulation intended to treat children infected with the human immunodeficiency virus (HIV).
According to a study, individuals who have been virally suppressed for years on antiretroviral medication may contain HIV in a subpopulation of white blood cells known as myeloid cells. Researchers demonstrated in the study that HIV can be reactivated and infect new cells in certain myeloid
Dallas (Texas) [US], September 21 (ANI): According to new research, people with HIV who also have untreated hepatitis C virus have a much higher risk of heart attack as they age, even if their HIV is treated.
Ohio [US], December 16 (ANI): A new study has found how a small difference in the RNA sequence can allow the viral RNA to be packaged for replication, creating potential targets for future HIV treatments.
Washington D.C. [USA], Aug 7 (ANI): Researchers have discovered a new potential medication that works with an HIV-infected person's own body to further suppress the ever present but silent virus that available HIV treatments are unable to combat.